188 related articles for article (PubMed ID: 9130279)
1. Different effects of tropisetron and ondansetron in learning and memory paradigms.
Pitsikas N; Borsini F
Pharmacol Biochem Behav; 1997 Apr; 56(4):571-6. PubMed ID: 9130279
[TBL] [Abstract][Full Text] [Related]
2. Flumazenil and tacrine increase the effectiveness of ondansetron on scopolamine-induced impairment of spatial learning in rats.
Diez-Ariza M; Redondo C; García-Alloza M; Lasheras B; Del Río J; Ramírez MJ
Psychopharmacology (Berl); 2003 Aug; 169(1):35-41. PubMed ID: 12845416
[TBL] [Abstract][Full Text] [Related]
3. Dose-related impairment of spatial learning by intrahippocampal scopolamine: antagonism by ondansetron, a 5-HT3 receptor antagonist.
Carli M; Luschi R; Samanin R
Behav Brain Res; 1997 Jan; 82(2):185-94. PubMed ID: 9030400
[TBL] [Abstract][Full Text] [Related]
4. Systemic injection of p-chloroamphetamine eliminates the effect of the 5-HT3 compounds on learning.
Hong E; Meneses A
Pharmacol Biochem Behav; 1996 Apr; 53(4):765-9. PubMed ID: 8801576
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of memory retrieval and attenuation of scopolamine-induced amnesia following administration of 5-HT3 antagonist ICS 205-930.
Chugh Y; Saha N; Sankaranarayanan A; Datta H
Pharmacol Toxicol; 1991 Aug; 69(2):105-6. PubMed ID: 1775428
[TBL] [Abstract][Full Text] [Related]
6. 5-HT3 receptors in selective animal models of cognition.
Sridhar N; Veeranjaneyulu A; Arulmozhi DK; Gupta CN; Babu RJ
Indian J Exp Biol; 2002 Feb; 40(2):174-80. PubMed ID: 12622180
[TBL] [Abstract][Full Text] [Related]
7. Ondansetron amelioration of scopolamine induced cognitive deficits in three-panel runway apparatus in rats.
Kumar N; Kela AK
Indian J Exp Biol; 2004 Sep; 42(9):919-21. PubMed ID: 15462187
[TBL] [Abstract][Full Text] [Related]
8. 5-HT3 antagonists reduce morphine self-administration in rats.
Hui SC; Sevilla EL; Ogle CW
Br J Pharmacol; 1993 Dec; 110(4):1341-6. PubMed ID: 8306073
[TBL] [Abstract][Full Text] [Related]
9. 5-HT3 receptor-independent inhibition of the depolarization-induced 86Rb efflux from human neuroblastoma cells, TE671, by ondansetron.
Toral J; Hu W; Critchett D; Solomon AJ; Barrett JE; Sokol PT; Ziai MR
J Pharm Pharmacol; 1995 Jul; 47(7):618-22. PubMed ID: 8568632
[TBL] [Abstract][Full Text] [Related]
10. Serotonergic innervation of the hippocampus and nucleus accumbens septi and the anxiolytic-like action of the 5-HT3 receptor antagonists.
Stefański R; Pałejko W; Bidziński A; Kostowski W; Płaźnik A
Neuropharmacology; 1993 Oct; 32(10):987-93. PubMed ID: 7905195
[TBL] [Abstract][Full Text] [Related]
11. Effects of St-587 and prazosin on water maze and passive avoidance performance of scopolamine-treated rats.
Puumala T; Sirviö J; Ruotsalainen S; Riekkinen P
Pharmacol Biochem Behav; 1996 Sep; 55(1):107-15. PubMed ID: 8870045
[TBL] [Abstract][Full Text] [Related]
12. Ondansetron fails to attenuate a scopolamine-induced deficit in a Stone maze task.
Bratt AM; Kelly ME; Domeney AM; Naylor RJ; Costall B
Neuroreport; 1994 Oct; 5(15):1921-4. PubMed ID: 7841377
[TBL] [Abstract][Full Text] [Related]
13. The effect of several putative cognition enhancers on a water maze acquisition deficit produced by pCPA + scopolamine combination treatment.
Harder JA; Kelly ME
Pharmacol Biochem Behav; 1997 Apr; 56(4):657-61. PubMed ID: 9130291
[TBL] [Abstract][Full Text] [Related]
14. Attenuation of scopolamine-induced and age-associated memory impairments by the sigma and 5-hydroxytryptamine(1A) receptor agonist OPC-14523 (1-[3-[4-(3-chlorophenyl)-1-piperazinyl]propyl]-5-methoxy-3,4-dihydro-2[1H]-quinolinone monomethanesulfonate).
Tottori K; Nakai M; Uwahodo Y; Miwa T; Yamada S; Oshiro Y; Kikuchi T; Altar CA
J Pharmacol Exp Ther; 2002 Apr; 301(1):249-57. PubMed ID: 11907181
[TBL] [Abstract][Full Text] [Related]
15. Comparison of the effects of the 5-HT3 receptor antagonists WAY-100579 and ondansetron on spatial learning in the water maze in rats with excitotoxic lesions of the forebrain cholinergic projection system.
Hodges H; Sowinski P; Turner JJ; Fletcher A
Psychopharmacology (Berl); 1996 May; 125(2):146-61. PubMed ID: 8783389
[TBL] [Abstract][Full Text] [Related]
16. The 5-HT(6) receptor antagonist SB-271046 reverses scopolamine-disrupted consolidation of a passive avoidance task and ameliorates spatial task deficits in aged rats.
Foley AG; Murphy KJ; Hirst WD; Gallagher HC; Hagan JJ; Upton N; Walsh FS; Regan CM
Neuropsychopharmacology; 2004 Jan; 29(1):93-100. PubMed ID: 14571256
[TBL] [Abstract][Full Text] [Related]
17. Nociceptin/orphanin FQ and nocistatin on learning and memory impairment induced by scopolamine in mice.
Hiramatsu M; Inoue K
Br J Pharmacol; 1999 Jun; 127(3):655-60. PubMed ID: 10401555
[TBL] [Abstract][Full Text] [Related]
18. Response heterogeneity of 5-HT3 receptor antagonists in a rat visceral hypersensitivity model.
Langlois A; Pascaud X; Junien JL; Dahl SG; Rivière PJ
Eur J Pharmacol; 1996 Dec; 318(1):141-4. PubMed ID: 9007525
[TBL] [Abstract][Full Text] [Related]
19. Reversal of neuroleptic-induced orofacial dyskinesia by 5-HT3 receptor antagonists.
Naidu PS; Kulkarni SK
Eur J Pharmacol; 2001 May; 420(2-3):113-7. PubMed ID: 11408032
[TBL] [Abstract][Full Text] [Related]
20. Intact learning and memory in rats following treatment with the dual orexin receptor antagonist almorexant.
Dietrich H; Jenck F
Psychopharmacology (Berl); 2010 Oct; 212(2):145-54. PubMed ID: 20631993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
